Sign in
Taking peopleNo phase

Deep Brain Stimulation for Obsessive-compulsive Disorder

Key facts

Who runs it
Umeå University
Where
Sweden1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
26 people, planned
Started
11 Sept 2018
Expected to end
31 Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Deep brain stimulation
Record updated
17 October 2024

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • OCD diagnosed according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
  • The patients should have received at least 16 sessions of cognitive behavioral therapy, tried three different serotonergic antidepressants in adequate doses for three months, and one serotonergic antidepressant in combination with a neuroleptic drug
  • Severe OCD symptoms: YBOCS ≥ 25 points
  • Substantial incapacity because of his/her symptoms
  • Duration of symptoms: 5 years minimum
  • Understand the consequences of participation in the study and give informed written consent

Who cannot take part

  • Not being able to understand the consequences of the treatment
  • Diagnosed with intellectual disability according to DSM-IV
  • Not meeting the requirements for the neurosurgery procedure

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Obsessive-compulsive disorder

This trial is currently available in Sweden.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate the treatment method of deep brain stimulation (DBS) in patients diagnosed with severe and treatment-resistant obsessive-compulsive disorder (OCD). DBS will be administered into the brain area of the bed nucleus of stria terminalis (BNST).

Read full original descriptionShow less

The main research questions are:

* Does active DBS in BNST reduce OCD symptoms (primary outcome)? * Does active DBS in BNST reduce anxiety or depressive symptoms and improve the level of daily function?

The participants will be randomized to active or sham DBS in the BNST for six months and we will measure the outcomes before DBS surgery, and six months post-surgery. After the randomization phase, the participants will enter an open-label phase and receive continuous DBS in BNST. Yearly follow-ups will be conducted. The outcomes will be measured through interviews using validated psychometric scales.

The 2 groups in the trial

  • Active stimulationExisting treatment, for comparison

    Deep brain stimulation - active stimulation

    Treatment: Deep brain stimulation

  • Sham stimulationSham treatment, for comparison

    Deep brain stimulation - no stimulation

    Treatment: Deep brain stimulation

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Deep Brain Stimulation for the Treatment of Severe Obsessive-compulsive Disorder
Criteria questions
Built from NCT06628752, who can take part
Record updated
17 October 2024